Skip to main content
. 2017 Jul 4;2017(7):CD012717. doi: 10.1002/14651858.CD012717
Study identifier (ID)
References
(* main reference)
Trial registry and ID
Participant characteristics
Age
Gender
Ethnicity
Comorbidities
Clinical assessment of the hip. Dislocated hip (reducible or not reducible), clinically unstable hip (i.e. dislocatable), or clinically stable hip
Ultrasound assessment of the hip. Acetabular dysplasia assessed using the alpha angle according to Graf classification of hip: I (normal), IIa or IIb (centred hip, 50 to 60 degrees of dysplasia), IIc (centred hip 43 to 50 degrees of dysplasia), III (de‐centred hip), and IV (dislocated hip)
Unilateral or bilateral disease
Trial characteristics
Trial design
Single centre or multicentre
Country/countries
How was participant eligibility defined?
How many people were randomised?
Number of participants in each intervention group
Number of participants who received intended treatment
Number of participants who were analysed
Splint used (include details of timing, weaning, etc.)
Comparator (include details of timing, weaning, etc.)
Risk of bias
Item Comment Judgement
Allocation of intervention High/low/unclear
Concealment of allocation High/low/unclear
Blinding of participants and personnel High/low/unclear
Blinding of outcome assessment High/low/unclear
Incomplete outcome data High/low/unclear
Selective outcome reporting High/low/unclear
Other potential threats to validity High/low/unclear
Outcomes Intervention Control Time point
Measurement of acetabular index, as determined by radiographs (angle) 1 year/2 years/5 years/other (specify)
Need for operative intervention to achieve reduction
Need for operative intervention to address dysplasia
Avascular necrosis (include grading system)
Femoral nerve palsy
Other nerve palsies
Health economic assessment (including financial impact on the family)
Bonding between parents and child (including obstacles to breastfeeding, problems with winding and bathing baby)
Fine motor skill development